Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Dynamic mRNA and miRNA expression analysis in response to intermuscular bone development of blunt snout bream (Megalobrama amblycephala).

Wan SM, Yi SK, Zhong J, Nie CH, Guan NN, Zhang WZ, Gao ZX.

Sci Rep. 2016 Aug 3;6:31050. doi: 10.1038/srep31050.

2.

Beta-Catenin Haplo Insufficient Male Mice Do Not Lose Bone in Response to Hindlimb Unloading.

Maurel DB, Duan P, Farr J, Cheng AL, Johnson ML, Bonewald LF.

PLoS One. 2016 Jul 13;11(7):e0158381. doi: 10.1371/journal.pone.0158381. eCollection 2016.

3.

Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges.

MacNabb C, Patton D, Hayes JS.

J Osteoporos. 2016;2016:6217286. doi: 10.1155/2016/6217286. Epub 2016 May 26. Review.

4.

The Bone Microenvironment: a Fertile Soil for Tumor Growth.

Buenrostro D, Mulcrone PL, Owens P, Sterling JA.

Curr Osteoporos Rep. 2016 Aug;14(4):151-8. doi: 10.1007/s11914-016-0315-2. Review.

PMID:
27255469
5.

Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.

Kedlaya R, Kang KS, Hong JM, Bettagere V, Lim KE, Horan D, Divieti-Pajevic P, Robling AG.

Endocrinology. 2016 Aug;157(8):3047-57. doi: 10.1210/en.2015-1587. Epub 2016 Jun 2.

PMID:
27253995
6.

The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.

Duan P, Bonewald LF.

Int J Biochem Cell Biol. 2016 Aug;77(Pt A):23-9. doi: 10.1016/j.biocel.2016.05.015. Epub 2016 May 19. Review.

PMID:
27210503
7.

PTH Signaling and Epigenetic Control of Bone Remodeling.

Ricarte F, Nakatani T, Partridge N.

Curr Mol Biol Rep. 2016 Mar;2(1):55-61. Epub 2016 Feb 3.

PMID:
27152252
8.

The biological function of type I receptors of bone morphogenetic protein in bone.

Lin S, Svoboda KK, Feng JQ, Jiang X.

Bone Res. 2016 Apr 5;4:16005. doi: 10.1038/boneres.2016.5. eCollection 2016. Review.

9.

Knee loading inhibits osteoclast lineage in a mouse model of osteoarthritis.

Li X, Yang J, Liu D, Li J, Niu K, Feng S, Yokota H, Zhang P.

Sci Rep. 2016 Apr 18;6:24668. doi: 10.1038/srep24668.

10.

Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.

Mohammed MK, Shao C, Wang J, Wei Q, Wang X, Collier Z, Tang S, Liu H, Zhang F, Huang J, Guo D, Lu M, Liu F, Liu J, Ma C, Shi LL, Athiviraham A, He TC, Lee MJ.

Genes Dis. 2016 Mar;3(1):11-40. Epub 2016 Jan 14.

11.

The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis.

Sun M, Zhou X, Chen L, Huang S, Leung V, Wu N, Pan H, Zhen W, Lu W, Peng S.

Biomed Res Int. 2016;2016:1652417. doi: 10.1155/2016/1652417. Epub 2016 Mar 17. Review.

12.

Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through β-Catenin.

Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, Li M, Zhang H, Xue X, Hou Z, Zhou Y, Yu Z, He G, Luo X.

Stem Cell Reports. 2016 Apr 12;6(4):579-91. doi: 10.1016/j.stemcr.2016.02.002. Epub 2016 Mar 3. Erratum in: Stem Cell Reports. 2016 Apr 12;6(4):633.

13.

Myeloma bone disease: Pathophysiology and management.

Silbermann R, Roodman GD.

J Bone Oncol. 2013 Apr 18;2(2):59-69. doi: 10.1016/j.jbo.2013.04.001. eCollection 2013 Jun. Review.

14.

Frontal Bone Insufficiency in Gsk3β Mutant Mice.

Szabo-Rogers H, Yakob W, Liu KJ.

PLoS One. 2016 Feb 17;11(2):e0149604. doi: 10.1371/journal.pone.0149604. eCollection 2016.

15.

MEKK2 mediates an alternative β-catenin pathway that promotes bone formation.

Greenblatt MB, Shin DY, Oh H, Lee KY, Zhai B, Gygi SP, Lotinun S, Baron R, Liu D, Su B, Glimcher LH, Shim JH.

Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1226-35. doi: 10.1073/pnas.1600813113. Epub 2016 Feb 16.

PMID:
26884171
16.

Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.

Zhang D, Hu M, Chu T, Lin L, Wang J, Li X, Ke HZ, Qin YX.

Bone. 2016 Jun;87:161-8. doi: 10.1016/j.bone.2016.02.005. Epub 2016 Feb 8.

PMID:
26868528
17.

Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse.

Sun W, Shi Y, Lee WC, Lee SY, Long F.

Bone. 2016 Apr;85:1-8. doi: 10.1016/j.bone.2016.01.013. Epub 2016 Jan 15.

18.

Regulation of bone metabolism by Wnt signals.

Kobayashi Y, Uehara S, Udagawa N, Takahashi N.

J Biochem. 2016 Apr;159(4):387-92. doi: 10.1093/jb/mvv124. Epub 2015 Dec 28. Review.

PMID:
26711238
19.

Osteocytes and Skeletal Pathophysiology.

Delgado-Calle J, Bellido T.

Curr Mol Biol Rep. 2015 Dec;1(4):157-167. Epub 2015 Oct 6.

PMID:
26693137
20.

Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.

Galán-Díez M, Isa A, Ponzetti M, Nielsen MF, Kassem M, Kousteni S.

Biochim Biophys Acta. 2016 Mar;1863(3):490-8. doi: 10.1016/j.bbamcr.2015.11.037. Epub 2015 Dec 8.

PMID:
26681532
Items per page

Supplemental Content

Write to the Help Desk